Gilead, Bristol-Myers file reply brief backing dismissal of claims in HIV-drug antitrust case
MLex Summary: Gilead and Bristol-Myers Squibb filed a reply brief in support of dismissing KPH Healthcare Services and FWK Holdings’ antitrust claims over a combination antiretroviral therapy used to treat human...To view the full article, register now.
Already a subscriber? Click here to view full article